SOPHiA GENETICS SA (SOPH) stock
Close on Nov 17, 2026Market cap $510.22MP/E –Yield –
Earnings
SOPHiA GENETICS's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of SOPHiA GENETICS's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | Aug 4, 2026before the open | $23.31M | +27.2% | -$0.30 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 3, 2026before the open | $21.70M | +22.6% | -$0.28 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 5, 2025before the open | $18.32M | +15.9% | -$0.33 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 4, 2025before the open | $17.70M | +4.1% | -$0.23 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 6, 2024before the open | $15.81M | +5.0% | -$0.23 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 5, 2024before the open | $17.00M | – | -$0.37 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 8, 2023before the open | $15.05M | – | -$0.33 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 7, 2023before the open | – | – | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 9, 2022before the open | – | – | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 15, 2022before the open | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
SOPHiA GENETICS's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Full-year revenueGAAP | FY2026 | $92.00M – $94.00M | – | New | Mar 3, 2026 |
| Adjusted EBITDA lossnon-GAAP | FY2026 | $29.00M – $32.00M | – | New | Mar 3, 2026 |
Guidance history
Every forecast SOPHiA GENETICS put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Mar 3, 2026 | Adjusted EBITDA loss | FY2026 | $29.00M – $32.00M | New |
| Mar 3, 2026 | Full-year revenue | FY2026 | $92.00M – $94.00M | New |
| Mar 4, 2025 | Adjusted EBITDA loss | FY2025 | $35.00M – $39.00M | New |
| Mar 4, 2025 | Full-year revenue | FY2025 | $72.00M – $76.00M | New |
| Mar 5, 2024 | Adjusted gross margin | FY2024 | 72.5% – 72.7% | New |
| Mar 5, 2024 | Adjusted operating loss | FY2024 | $45.00M – $50.00M | New |
| Mar 5, 2024 | Revenue | FY2024 | $78.00M – $81.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases SOPHiA GENETICS filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
See a number that looks wrong?